Lactic acid bacteria having action of lowering blood uric acid level
Various types of lactic acid bacteria were cultured in the presence of a purine, the amount of the purine consumed and the amount of purine degradation products produced were measured, and several lactic acid bacteria showing remarkable purine-decomposing ability were selected. Lactic acid bacteria that were assessed to have high purine-decomposing ability according to the above-mentioned selection were orally administered to rats reared on purine-containing feed, the general status and serum uric acid level of the rats were measured, and the effect of lactic acid bacteria administration on serum uric acid levels was examined. As a result, lactic acid bacteria that significantly suppress the increase of serum uric acid levels, Lactobacillus gasseri OLL2959 and Lactobacillus oris OLL2779, were found.
1. A lactic acid bacterium Lactobacillus gasseri strain OLL2959 deposited as Accession No.: NITE BP-224, wherein the lactic acid bacterium is a biologically pure culture thereof.
2. A dietary product for suppressing an increase in blood uric acid level, comprising the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.
3. A pharmaceutical for suppressing an increase in blood uric acid level, comprising the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.
4. A pharmaceutical for treating hyperuricemia, comprising the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.
5. A dietary product for treating hyperuricemia, comprising the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.
6. A method for suppressing the level of purine ingested from food, wherein the method comprises administering the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.
7. A method for suppressing an increase in blood uric acid level, wherein the method comprises administering the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.
8. A method for producing a dietary product with reduced purine level, wherein the method comprises the step of contacting a raw material or intermediate product of the dietary product with the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.
9. A method for treating any one or more diseases or symptoms from the group consisting of hyperuricemia, gout, renal dysfunction, urinary stone, and arteriosclerosis, wherein the method comprises administering the lactic acid bacterium of claim 1 , and/or a substance containing said lactic acid bacterium.